Neurobiology of Aging
Volume 29, Issue 7 , Pages 1060-1069 , July 2008

β2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals

Received 17 September 2006 ,Revised 29 January 2007 ,Accepted 5 February 2007.

References 

  1. Albert MS. The ageing brain: normal and abnormal memory. Phil. Trans. Roy. Soc. Lond. B. 1997;352:1703–1709
  2. Ando S, Ohashi Y. Longitudinal study on age-related changes of working and reference memory in the rat. Neurosci. Lett. 1991;128:17–20
  3. Aoki C. Beta-adrenergic receptors: astrocytic localization in the adult visual cortex and their relation to catecholamine axon terminals as revealed by electron microscopic immunocytochemistry. J. Neurosci. 1992;12(3):781–792
  4. Aoki C, Pickel VM. Ultrastructural relations between beta-adrenergic receptors and catecholaminergic neurons. Brain. Res. Bull. 1992;29(3–4):257–263
  5. Aoki C, Venkatesan C, Kurose H. Noradrenergic modulation of the prefrontal cortex as revealed by electron microscopic immunocytochemistry. Adv. Pharmacol. 1998;42:777–780
  6. Arnsten AFT, Goldman-Rakic PS. Alpha-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged non-human primates. Science. 1985;230:1273–1276
  7. Baronti A, Grieco A, Vibelli C. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study. Int. J. Clin. Pharmacol. Ther. Toxicol. 1980;18(1):21–25
  8. Bartus RT, Fleming D, Johnson HR. Aging in the rhesus monkey: debilitating effects on short-term memory. J. Gerontol. 1978;33:858–871
  9. Berridge CW, Bolen SJ, Manley MS, Foote SL. Modulation of forebrain electroencephalographic (EEG) activity in the halothane-anesthetized rat via actions of noradrenergic beta-receptors located within the medial septal region of the basal forebrain. J. Neurosci. 1996;16:7010–7020
  10. Bimonte HA, Nelson ME, Granholm AC. Age-related deficits as working memory load increases: relationships with growth factors. Neurobiol. Aging. 2003;24(1):37–48
  11. Birnbaum SG, Gobeske KT, Auerbach J, Taylor JR, Arnsten AFT. A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in prefrontal cortex. Biol. Psychiat. 1999;46:1266–1274
  12. Blanco A, Flores-Acuna F, Roldan-Villalobos R, Monterde JG. Testicular damage from anabolic treatments with the beta(2)-adrenergic agonist clenbuterol in pigs: a light and electron microscope study. Vet. J. 2002;163(3):292–298
  13. Blanco A, Artacho-Perula E, Flores-Acuna R, Moyano R, Monterde JG. Quantitative changes in the normal and apoptotic thymocytes of pigs treated with anabolic doses of the beta2 adrenergic agonist clenbuterol. Vet. Immunol. Immunopathol. 2003;96(1–2):111–115
  14. Boner AL, Sette L, Castellani C, Schiassi M. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma. J. Asthma. 1987;24(6):347–353
  15. Bonnet N, Brunet-Imbault B, Arlettaz A, Horcajada MN, Collomp K, Benhamou CL, et al. Alteration of trabecular bone under chronic beta2 agonists treatment. Med. Sci. Sports Exerc. 2005;37(9):1493–1501
  16. Brambilla G, Cenci T, Franconi F, Galarini R, Macri A, Rondoni F, et al. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol. Lett. 2000;114(1–3):47–53
  17. Brusasco V, Vibelli C, Chierichetti S, Ramoino R. Dose–response study of a new oral bronchodilator, NAB 365 (clenbuterol). Int. J. Clin. Pharmacol. Biopharm. 1978;16(12):589–593
  18. Bunge SA, Ochsner KN, Desmond JE, Glover GH, Gabrieli JD. Prefrontal regions involved in keeping information in and out of mind. Brain. 2001;124:2074–2086
  19. Burniston JG, Ng Y, Clark WA, Colyer J, Tan LB, Goldspink DF. Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J. Appl. Physiol. 2002;93(5):1824–1832
  20. Burniston JG, Clark WA, Tan LB, Goldspink DF. Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles. Muscle Nerve. 2006;33(5):655–663
  21. Cahill L, Prins B, Weber M, McGaugh JL. Beta-adrenergic activation and memory for emotional events. Nature. 1994;371:702–704
  22. Chao LL, Knight RT. Age-related prefrontal alterations during auditory memory. Neurobiol. Aging. 1997;18:87–95
  23. Choo JJ, Horan MA, Little RA, Rothwell NJ. Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation. Am. J. Physiol. 1992;263:E50–E56
  24. Constantinidis C, Williams GV, Goldman-Rakic PS. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nat. Neurosci. 2002;5(2):175–180
  25. De Santi S, de Leon MJ, Convit A, Tarshish C, Rusinek H, Tsui WH, et al. Age-related changes in brain. II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects. Psychiat. Quart. 1995;66(4):357–370
  26. Divac I. Frontal lobe system and spatial reversal in the rat. Neuropsychologia. 1971;9:175–183
  27. Downs, J.L., Dunn, M.R., Borok, E., Shanabrough, M., Horvath, T.L., Kohama, S.G., Urbanski, H.F., 2006. Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque. Neurobiol. Aging (Online).
  28. Eberling JL, Roberts JA, Rapp PR, Tuszynski MH, Jagust WJ. Cerebral glucose metabolism and memory in aged rhesus macaques. Neurobiol. Aging. 1997;18(4):437–443
  29. Ferry B, Roozendaal B, McGaugh JL. Basolateral amygdala noradrenergic influences on memory storage are mediated by an interaction between beta- and alpha-1-adrenoceptors. J. Neurosci. 1999;19:5119–5123
  30. Fillenz M, Lowry JP. Studies of the source of glucose in the extracellular compartment of the rat brain. Dev. Neurosci. 1998;20(4–5):365–368
  31. Fillenz M, Lowry JP, Boutelle MG, Fray AE. The role of astrocytes and noradrenaline in neuronal glucose metabolism. Acta Physiol. Scand. 1999;167:275–284
  32. Flugge G, Ahrens O, Fuchs E. Beta-adrenoceptors in the tree shrew brain. II. Time-dependent effects of chronic psychosocial stress on [125I]iodocyanopindolol bindings sites. Cell. Mol. Neurobiol. 1997;17(4):401–415
  33. Franowicz JS, Kessler L, Dailey-Borja CM, Kobilka BK, Limbird LE, Arnsten AFT. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J. Neurosci. 2002;22:8771–8777
  34. Goldman-Rakic PS, Lidow MS, Gallager DW. Overlap of dopaminergic, adrenergic, and serotonergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci. 1990;10:2125–2138
  35. Herndon JG, Moss MB, Rosene DL, Killiany RJ. Patterns of cognitive decline in aged rhesus monkeys. Behav. Brain Res. 1997;87:25–34
  36. Hesketh JE, Campbell GP, Lobley GE, Maltin CA, Acamovic F, Palmer RM. Stimulation of actin and myosin synthesis in rat gastrocnemius muscle by clenbuterol; evidence for translational control. Comp. Biochem. Physiol. C. 1992;102(1):23–27
  37. Hoffman RJ, Hoffman RS, Freyberg CL, Poppenga RH, Nelson LS. Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. J. Toxicol. Clin. Toxicol. 2001;39(4):339–344
  38. Hopkins WF, Johnston D. Noradrenergic enhancement of long-term potentiation at mossy fiber synapses in the hippocampus. J. Neurophysiol. 1988;59:667–687
  39. Introini-Collison IB, Miyazaki B, McGaugh JL. Involvement of the amygdala in the memory-enhancing effects of clenbuterol. Psychopharmacology. 1991;104(4):541–544
  40. Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, Unnerstall JR. Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. J. Neurochem. 1989;53(6):1772–1781
  41. Kapur S, Craik FI, Jones C, Brown GM, Houle S, Tulving E. Functional role of the prefrontal cortex in retrieval of memories: a PET study. Neuroreport. 1995;6:1880–1884
  42. Kierzkowska B, Stanczyk J, Kasprzak JD. Myocardial infarction in a 17-year-old body builder using clenbuterol. Circ. J. 2005;69(9):1144–1146
  43. Korol DL, Gold PE. Glucose, memory, and aging. Am. J. Clin. Nutr. 1998;67(4):764–771
  44. Lepage M, Ghaffar O, Nyberg L, Tulving E. Prefrontal cortex and episodic memory retrieval mode. Proc. Natl. Acad. Sci. U.S.A. 2000;97:506–511
  45. Li B-M, Mei Z-T. Delayed response deficit induced by local injection of the alpha-2 adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. Behav. Neural Biol. 1994;62:134–139
  46. McIntyre CK, Miyashita T, Setlow B, Marjon KD, Steward O, Guzowski JF, et al. Memory-influencing intra-basolateral amygdala drug infusions modulate expression of Arc protein in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2005;102(30):10718–10723
  47. Navegantes LC, Resano NM, Migliorini RH, Kettelhut IC. Catecholamines inhibit Ca(2+)-dependent proteolysis in rat skeletal muscle through beta(2)-adrenoceptors and cAMP. Am. J. Physiol. Endocrinol. Metab. 2001;281(3):E449–E454
  48. Ng GY, da S, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst. Rev. 2001;3:CD003214
  49. Nicholas AP, Pieribone VA, Hokfelt T. Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: an in situ hybridization study. Neuroscience. 1993;56:1023–1039
  50. Nielsen-Bohlman L, Knight RT. Prefrontal alterations during memory processing in aging. Cerebral Cortex. 1995;5:541–549
  51. Noda A, Ohba H, Kakiuchi T, Futatsubashi M, Tsukada H, Nishimura S. Age-related changes in cerebral blood flow and glucose metabolism in conscious rhesus monkeys. Brain Res. 2002;936(1–2):76–81
  52. Noguchi M, Eguchi Y, Ichiki J, Yahara J, Noda S. Therapeutic efficacy of clenbuterol for urinary incontinence after radical prostatectomy. Int. J. Urol. 1997;4(5):480–483
  53. Ordway GA, O’Donnell JM, Frazer A. Effects of clenbuterol on beta-1 and beta-2 adrenergic receptors of the rat. J. Pharm. Exp. Ther. 1987;241(1):187–195
  54. Prather ID, Brown DE, North P, Wilson JR. Clenbuterol: a substitute for anabolic steroids?. Med. Sci. Sports Exerc. 1995;27(8):1118–1121
  55. Rainbow TC, Parsons B, Wolfe BB. Quantitative autoradiography of beta1- and beta2-adrenergic receptors in rat brain. Proc. Natl. Acad. Sci. U.S.A. 1984;81:1585–1589
  56. Ramos, B., Colgan, L., Nou, E., Arnsten, A.F.T., 2005. The b1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys. Biol. Psychiat. (Online).
  57. Rao SG, Williams GV, Goldman-Rakic PS. Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J. Neurosci. 2000;20(1):485–494
  58. Rapp PR, Amaral DG. Evidence for task-dependent memory dysfunction in the aged monkey. J. Neurosci. 1989;9:3568–3576
  59. Richman JG, Brady AE, Wang Q, Hensel JL, Colbran RJ, Limbird LE. Agonist-regulated Interaction between alpha2-adrenergic receptors and spinophilin. J. Biol. Chem. 2001;276(18):15003–15008
  60. Roozendaal B, Quirarte GL, McGaugh JL. Glucocorticoids interact with the basolateral amygdala beta-adrenoceptor—cAMP/cAMP/PKA system in influencing memory consolidation. Eur. J. Neurosci. 2002;15:553–560
  61. Ryall JG, Plant DR, Gregorevic P, Sillence MN, Lynch GS. Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats. J. Physiol. 2004;555:175–188
  62. Schacter DL, Savage CR, Alpert NM, Rauch SL, Albert MS. The role of hippocampus and frontal cortex in age-related memory changes: a PET study. Neuroreport. 1996;7:1165–1169
  63. Sessler FM, Mouradian RD, Cheng JT, Yeh HH, Liu WM, Waterhouse BD. Noradrenergic potentiation of cerebellar Purkinje cell responses to GABA: evidence for mediation through the beta-adrenoceptor-coupled cyclic AMP system.. Brain. Res. Rev. 1989;499:27–38
  64. Sleeper MM, Kearns CF, McKeever KH. Chronic clenbuterol administration negatively alters cardiac function. Med. Sci. Sports Exerc. 2002;34(4):643–650
  65. In:  Stuss DT,  Knight RT editor. Principles of Frontal Lobe Function. NY: Oxford University Press; 2002;p. 616
  66. Summers RJ, Papaioannou M, Harris S, Evans BA. Expression of beta 3-adrenoceptor mRNA in rat brain. Br. J. Pharmacol. 1995;116(6):2547–2548
  67. Taylor JR, Birnbaum SG, Ubriani R, Arnsten AFT. Activation of protein kinase A in prefrontal cortex impairs working memory performance. J. Neurosci. 1999;19:RC23;(Online)
  68. Tevaearai HT, Koch WJ. Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts. Trends Cardiovasc. Med. 2004;14:252–256
  69. Waterhouse BD, Moises HC, Woodward DJ. Noradrenergic modulation of somatosensory cortical neuronal responses to iontophoretically applied putative transmitters. Exp. Neurol. 1980;69:30–49
  70. Waterhouse BD, Moises HC, Woodward DJ. Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine. Neuropharmacology. 1981;20:907–920
  71. Yimlamai T, Dodd SL, Borst SE, Park S. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. J. Appl. Physiol. 2005;99(1):71–80
  72. Yoshimura T, Kurita C, Nagao T, Usami E, Nakao T, Watanabe S, et al. Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Pharmacology. 1997;54(3):144–152
  73. Zhang HT, Huang Y, Mishler K, Roerig SC, O’Donnell JM. Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats. Psychopharmacology (Berl.). 2005;182(1):104–115

PII: S0197-4580(07)00044-9

doi: 10.1016/j.neurobiolaging.2007.02.003

Neurobiology of Aging
Volume 29, Issue 7 , Pages 1060-1069 , July 2008

Article Tools

* Image Usage & Resolution